Cleft Lip and Palate Midfacial Hypoplasia: Criteria to Choose the Treatment
dc.contributor.author | Farina, Rodrigo | |
dc.contributor.author | Lolas, Jorge | |
dc.contributor.author | Moreno, Emilio | |
dc.contributor.author | Alister, Juan Pablo | |
dc.contributor.author | Uribe, Maria Francisca | |
dc.contributor.author | Pantoja, Roberto | |
dc.contributor.author | Valladares, Salvador | |
dc.contributor.author | Arrue, Camila | |
dc.date.accessioned | 2025-01-20T21:12:01Z | |
dc.date.available | 2025-01-20T21:12:01Z | |
dc.date.issued | 2022 | |
dc.description.abstract | A series of skeletal and dentoalveolar/occlusal criteria were proposed for choosing the treatment modality for the management of midface hypoplasia in cleft lip/palate patients, focusing on functional improvement, aesthetics, and minimizing the risk of recurrence and secondary alterations. For which, 42 patients with nonsyndromic cleft lip/palate, all with previous primary lip/palate surgeries and without previous osteotomies, were analyzed. Orthognathic surgery (OS) (n = 24) and maxillary distraction osteogenesis (n = 18) with anterior segmental osteotomies (segmental distraction osteogenesis [SD]), alveolar transport disc (TD), and midface total distraction osteogenesis (TDO) by modified Le Fort III osteotomy was done. The average of maxillary advancement for OS was 5.58 +/- 0.83 mm, for SD 9.4 +/- 0.89 mm, for TD 8.00 +/- 1.00 mm, and for TDO was 8.13 +/- 1.55 mm. In the presence of infraorbital and/or zygomatic hypoplasia, TDO was performed using skeletal anchorage, with the requirement of occlusal stability in dental cast in occlusion. In short maxillary arch without dental cast feasibility in occlusion, hypodontia/agenesis or absence of premaxilla, TD and SD was performed. There was only 1 mm of recurrence in 1 patient of each group. Changes in speech were detected in 2 patients in the OS group (8.3%). Orthognathic surgery can be indicated for advancements <= 7 mm not requiring orbito-zygomatic advancement, whereas distraction osteogenesis can be indicated for advances >8 mm with or without the need for orbito-zygomatic advancement, in addition with other dentoalveolar factors and velopharyngeal function. | |
dc.fuente.origen | WOS | |
dc.identifier.doi | 10.1097/SCS.0000000000007973 | |
dc.identifier.eissn | 1536-3732 | |
dc.identifier.issn | 1049-2275 | |
dc.identifier.uri | https://doi.org/10.1097/SCS.0000000000007973 | |
dc.identifier.uri | https://repositorio.uc.cl/handle/11534/93640 | |
dc.identifier.wosid | WOS:000762006200073 | |
dc.issue.numero | 2 | |
dc.language.iso | en | |
dc.pagina.final | 501 | |
dc.pagina.inicio | 496 | |
dc.revista | Journal of craniofacial surgery | |
dc.rights | acceso restringido | |
dc.subject | Cleft lip and palate | |
dc.subject | dentofacial abnormalities | |
dc.subject | dentofacial deformity | |
dc.subject | distraction osteogenesis | |
dc.subject | maxillary hypoplasia | |
dc.subject | maxillary osteotomy | |
dc.subject | midfacial advancement | |
dc.subject | midfacial hypoplasia | |
dc.subject | orthognathic surgery | |
dc.subject.ods | 03 Good Health and Well-being | |
dc.subject.odspa | 03 Salud y bienestar | |
dc.title | Cleft Lip and Palate Midfacial Hypoplasia: Criteria to Choose the Treatment | |
dc.type | artículo | |
dc.volumen | 33 | |
sipa.index | WOS | |
sipa.trazabilidad | WOS;2025-01-12 |